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Restoration of leg length and offset 
correlates with trochanteric pain 
syndrome in total hip arthroplasty
Michael Worlicek1,2 ✉, Benedikt Messmer2, Joachim Grifka2, Tobias Renkawitz2 & 
Markus Weber2
persistent pain around the greater trochanter is a common complication after total hip arthroplasty. 
Restoration of biomechanics such as leg length, femoral und acetabular offset is crucial in THA. The 
purpose of this study was to evaluate postoperative differences of these parameters after THA and to 
analyze their association to greater trochanteric pain syndrome. Furthermore, we aimed to evaluate 
the clinical relevance of trochanteric pain syndrome compared to patient reported outcome measures. 
3D-CT scans of 90 patients were analyzed after minimalinvasive total hip arthroplasty and leg length, 
femoral and acetabular offset differences were measured. Clinical evaluation was performed three 
years after THA regarding the presence of trochanteric pain syndrome and using outcome measures. 
Furthermore, the patients’ expectation were evaluated. Patients with trochanteric pain syndrome 
showed a higher absolute discrepancy of combined leg length, femoral and acetabular offset 
restoration compared to the non-operated contralateral side with 11.8 ± 6.0 mm than patients without 
symptoms in the trochanteric region with 7.8 ± 5.3 mm (p = 0.01). Patients with an absolute deviation 
of the combined parameters of more than 5 mm complained more frequently about trochanteric 
symptoms (29.2%, 19/65) than patients with a biomechanical restoration within 5 mm compared to 
the non-affected contralateral side (8.0%, 2/25, p = 0.03). Clinical outcome measured three years after 
THA was significantly lower in patients with trochanteric symptoms than without trochanteric pain 
(p < 0.03). Similarly, fulfillment of patient expectations as measured by THR-Survey was lower in the 
patients with trochanteric pain (p < 0.005). An exact combined restoration of leg length, acetabular and 
femoral offset reduces significantly postoperative trochanteric pain syndrome and improves the clinical 
outcome of the patients.
Primary total hip arthroplasty (THA) is one of the most frequently performed orthopaedic operations worldwide, 
with an increasing number of patients due to an increasing expectation of life1. Persistent pain located around the 
greater trochanter is a common complication after THA impairing mobility and quality of life. In literature this 
is described as trochanteric pain syndrome and defined as disabling pain localized over the lateral aspect of the 
hip2,3. The prevalence of trochanteric pain syndrome is highly variable in literature. Tan et al. report a prevalence 
of of over 50% in patients presenting in the spine clinic. Barrett et al. mention a series prevalence of 27.5%. In 
addition MRI analysis show peritrochanteric lesion in over 30%4–6. Following total hip arthroplasty (THA) 4–17% 
of patients report these symptoms according to previous studies7–11. The reasons of trochanteric pain syndrome 
as reported in previous studies are manifold and include tendinopathy or microtrauma of the gluteus medius 
and minimus tendons, often without signs of inflammation12,13. In literature a female preponderance for Greater 
trochanteric pain syndrome in patients without THA has been described12.
Beside correct component positioning restoration of biomechanics such as leg length, femoral und acetabular 
offset is crucial in THA. A recent study showed that even leg length and offset differences over 5 mm are asso-
ciated with altered gait kinematics as measured in gait analysis after THA and thus emphasize the importance 
of successful biomechanical restoration14. Another study showed, that a reduced global femoral offset less than 
5 mm, leads to an aggravation in the functional outcome, especially of the abductor muscle strength15. This is in 
accordance with the findings of Spalding et al., who found a reduced motion and strength in the abductor muscle 
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after reduced femoral offset reconstruction in THA16. However, the correct radiographic evaluation of leg length 
and offset is challenging since plain radiographs harbor the risk of misinterpretation of these parameters due to 
the variable position of the pelvis in relation to the plane of the film. Especially assessment of femoral offset on 
plain radiographs seems to be defective and can be underestimated up to 40%17. In contrast three-dimensional 
computed tomography (3D-CT) enables exact evaluation of leg length and offset with inaccuracies below 1 mm18. 
To the best of the authors’ knowledge no study has analyzed the association of combined leg length and offset 
restoration and trochanteric pain syndrome after THA so far.
The purpose of this study was to evaluate postoperative leg length, femoral and acetabular offset differences 
after THA using 3D-CT and to analyze their association to greater trochanteric pain syndrome. Furthermore, we 
aimed to evaluate the clinical relevance of trochanteric pain syndrome compared to patient reported outcome 
measures (PROMs).
Material and methods
This study is a secondary outcome analysis of a registered, prospective controlled trial (DRKS00000739, German 
Clinical Trials Register)19. The primary outcome of this larger study was to assess whether the ROM of the pros-
thetic joint could be improved by computer-assisted functional optimization of position and containment of the 
acetabular component. A cohort of 783 patients with hip osteoarthritis was screened. The inclusion criteria of 
the initial study were: age between 50 and 75 years, an American Society of Anesthesiologists (ASA) score of ≤3, 
unilateral osteoarthritis of the hip (up to Kellgren 2 of the contralateral side), no prior hip surgery, and no hip 
dysplasia or trauma. In total, 597 patients did not meet the inclusion criteria. Altogether a consecutive series of 
135 patients were enrolled in this single center study.
The current study is a prospective analysis independent from the primary study. The primary study dealt 
with ROM improvement by computer-assisted, functional optimization of cup position in primary THA. In the 
current analysis, we focused on the clinical outcome and source of greater trochanteric pain syndrome after 
THA in relation to restoration of biomechanics such as leg length and offset. A sovereign power calculation was 
performed for the study endpoint reduction of postoperative greater trochanteric pain syndrome in relation to 
accuracy of biomechanical restoration. We assumed a reduction of greater trochanteric pain syndrome about 25% 
if leg length and offset was successfully restored. Based on these considerations, a total sample size of 84 (63/21) 
with 3 to 1 distribution achieved a power of 80% using a two-tailed t test on a two-sided 5% significance level 
(GPower 3.1, Düsseldorf, Germany).
According to the inclusion and exclusion criteria of the main study 135 patients undergoing 
minimally-invasive THA were included in the study. Postoperative 3D-CTs for leg length and offset measure-
ments were available for 123 study participants. Out of this 123 data sets 15 CT files were not compatible with the 
software for 3D-CT measurement of leg length, femoral and acetabular offset. Ninety patients of this subgroup 
were available for clinical follow up of trochanteric pain syndrome and PROMs three years after THA and thus 
included in the final analysis (Fig. 1). Characteristics of the study group are shown in Table 1. This investigation 
was approved by the local Ethics Committee of the University of Regensburg, Germany (No. 10-121-0263). All 
operations were performed in the lateral decubitus position through a minimally-invasive anterolateral approach 
to the hip at our Department of Orthopedic Surgery. Preoperative leg length and offset differences were measured 
on magnification-corrected low-centered anteroposterior pelvic radiographs. The aim during the operation was 
to restore leg length and offset in relation to the non-affected contralateral side.
Postoperatively, 3D-CTs were obtained in all patients and leg length, femoral and acetabular offset differences 
were measured. We chose 3D-CT for our analysis since measurements especially of femoral offset on plain radio-
graphs are susceptible to error. In contrast, 3D-CT offers the highest accuracy in estimation of leg length and off-
set independently of the position of the pelvis17. CT measurements were carried out using the ‘semi-automatical’ 
function of a digital 3D-CT-based planning software (Modicas, Erlangen, Germany). This software offers the 
possibility to assess hips in three dimensions, to exactly determine the axes and to automatically calculate angles 
and measure distances. First, the pelvis was virtually aligned in order to bring the anterior pelvic plain in congru-
ence with the coronal plain, to have a neutral pelvic tilt and so a constant starting point. In order to exclude any 
rotational errors both anterior superior iliac spines (ASIS) were orientated to the same height in the coronal, sag-
ittal and axial plane. Acetabular offset was defined as the shortest distance from the center of the femoral head to 
the bottom of the acetabulum (Fig. 2a), femoral offset was defined as the shortest distance from the center of the 
femoral head perpendicular to the femoral stem axis (Fig. 2b). Both sides were measured and the difference was 
built between operated and non-operated side. The nonoperated side was used as reference for the true offset and 
leg length. Correspondingly, to assess the leg length difference, the distance from the ASIS to the lesser trochanter 
was measured on both sides and the difference was built (Fig. 2c). For a comparable analysis, the absolute values 
of all three differences, independent if over- or under-corrected, were added together, to built a combined value 
of the measured parameters.
Clinical evaluation was performed three years after THA by an independent observer blinded to the radio-
graphic results, regarding the presence of trochanteric pain syndrome. Trochanteric pain syndrome was defined 
as tenderness on palpation of the greater trochanter and painful active abduction of the hip. Preoperatively and 
3 years after THA, outcome measures such as the Harris Hip Score (HHS)20, Hip Disability And Osteoarthritis 
Outcome Score (HOOS)21 and EuroQol (EQ-5D)22 were obtained. Furthermore, the patients’ expectation 
were evaluated using the Hospital for Special Surgery Total Hip Replacement Expectations (THR) Survey23. 
Preoperatively, none of the patients had symptoms of a trochanteric pain syndrome as defined before. The HHS 
first published in 1969 was established as a new method to evaluate the results after mold arthroplasty15. Since 
then it has been widely used for assessing outcome after hip surgery24. The HHS covers four dimensions: pain, 
function, deformity and range of motion. Altogether the HHS consists of 10 items resulting in a maximum score 
of 100 points. As a clinician based outcome measure it has be obtained by physician or other qualified health care 
3Scientific RepoRtS |         (2020) 10:7107  | https://doi.org/10.1038/s41598-020-62531-9
www.nature.com/scientificreportswww.nature.com/scientificreports/
professional. For interpretation score values 100–90 points represent an excellent result, 90–80 points a good 
result, 80–70 points a fair result and <70 points a poor results, respectively [9]. In contrast to HHS all other 
outcome measures in this study are patient reported. The HOOS was developed to measure outcome in patients 
with hip osteoarthritis. All Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)25 ques-
tions are included in the HOOS. In addition to WOMAC, HOOS contains subscales for sport and recreation 
function resulting in a better responsiveness especially in younger patients26. The HOOS consists of 5 subscales: 
pain, symptoms, activities of daily living, sport and quality of life built by 40 items. For standardized answers five 
Likert-boxes are available. The best scale is 100 points indicating no problems27. The EQ-5D is a widely used and 
tested descriptive instrument for evaluating health. It defines health based on five dimensions: Mobility, Self-Care, 
Usual Activities, Pain/Discomfort, and Anxiety/Depression. Each dimension has 3 response categories ranging 
from no problems, some problems to extreme problems. The EQ-5D was tested in general population and patient 
samples for valuing health28.
For statistical analysis, continuous data are presented as mean (standard deviation). Group comparisons were 
performed by Mann-Whitney-U-tests. Absolute and relative frequencies were given for categorical data and 
compared between groups by chi-square tests. All hypothesis in the study was tested on 5% significance level. 
Multivariate logistic regression including gender, age, ASA, BMI and Kellgren was performed to search for risk 
Figure 1. Consolidated Standards for Reporting Trials flow diagram for participants. (THA = total hip 
arthroplasty).
n = 90
Gender (female) (%) 47 (52.2)
Age (yrs) 62.1 (SD 7.8)
BMI (kg/m2) 26.6 (SD 3.9)
ASA 1 (%) 17 (18.9)
ASA 2 (%) 49 (54.4)
ASA 3 (%) 24 (26.7)
Treatment side (right) (%) 52 (57.8)
Table 1. Characteristics of the study group*. BMI = body mass index; ASA = American Society of 
Anaesthesiologists.
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Figure 2. (a) Measurement of the acetabular offset in the coronar plane. Acetabular offset was defined as the 
shortest distance from the center of the femoral head to the bottom of the acetabulum. Line a nonoperated side, 
line b after THA. (b) Measurement of the femoral offset. Femoral offset was defined as the shortest distance 
from the center of the femoral head perpendicular to the femoral shaft axis. Line c represents the femoral offset 
on the nonoperated side, line d represents the femoral offset after THA, line e represents the femoral shaft axis. 
(c) Measurement of the leg length difference. Line f represents the height of both anterior superior iliac spines, 
line g represents both lesser trochanter minors. The difference between line h and i represents the leg length 
difference.
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factors associated trochanteric pain syndrome after THA. IBM SPSS Statistics 22 (SPSS Inc, Chicago, IL, USA) 
was used for analysis.
ethical approval. This investigation was approved by the local Ethics Committee (No.10-121-0263). All pro-
cedures were in accordance with the ethical standards of the responsible committee on human experimentation 
and with the Helsinki Declaration of 1975, as revised in 2000.
informed consent. Informed consent was obtained from all individual participants included in the study.
Results
The prevalence of trochanteric pain syndrome in our cohort was 23.3% (21/90).
Patients with trochanteric pain syndrome three years after THA showed a higher absolute discrepancy of com-
bined leg length, femoral and acetabular offset restoration compared to the non-operated contralateral side with 
11.8 ± 6.0 mm than patients without symptoms in the trochanteric region with 7.8 ± 5.3 mm (p = 0.01; Fig. 3). 
Patients with an absolute deviation of combined biomechanical restoration of leg length, femoral and acetab-
ular offset of more than 5 mm complained more frequently about trochanteric symptoms (29.2%, 19/65) than 
patients with a biomechanical restoration within 5 mm compared to the non-affected contralateral side (8.0%, 
2/25, p = 0.03). In contrast, the discrepancy of one single biomechanical parameter such as leg length, femoral or 
acetabular offset was not different between patients with and without trochanteric symptoms (Table 2).
Clinical outcome measured three years after THA such as HHS, HOOS and EQ-5D was significantly lower 
in patients with trochanteric symptoms than in patients without trochanteric pain (p < 0.03, Table 3). Similarly, 
Figure 3. Patients with trochanteric pain syndrome three years after THA showed a higher absolute 
discrepancy of combined leg length, femoral and acetabular offset restoration compared to the non-operated 
contralateral side with 11.8 ± 6.0 mm than patients without symptoms in the trochanteric region with 
7.8 ± 5.3 mm (p = 0.01). ABS_Sum_Diff_LLFOAO = absolute sum of differences of leg length, femoral and 
acetabular offset compared to the non-operated side, TR pain = trochanteric pain syndrome.
LL (mm) FO (mm) AO (mm)
No pain
mean 4.9 4.4 4.3
SD 4.3 3.2 3.2
median 4.2 3.8 3.9
minimum 0.0 0.1 0.0
maximum 18.9 15.3 16.4
trochanteric 
pain syndrome
mean 6.7 5.4 3.8
SD 5.6 3.7 2.7
median 5.6 5.2 2.6
minimum 0.6 0.7 0.8
maximum 25.4 16.0 10.4
p-value 0.10 0.26 0.45
Table 2. Discrepancy (absolute values) of one single biomechanical parameter such as leg length (LL), femoral 
(FO) or acetabular offset (AO) was not different between patients with and without trochanteric symptoms. 
SD = Standard Deviation.
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fulfillment of patient expectations as measured by THR-Survey was lower in the patient with trochanteric pain at 
each followup point (p < 0.005). In contrast, no differences in clinical socres were observed in the preoperative 
situation.
Multivariate analysis confirmed the independent association of trochanteric pain syndrome and accuracy 
of combined biomechanical restoration of leg length, femoral and acetabular offset (OR 1.1, 95% CI 1.0–1.3, 
p = 0.006) whereas other parameters such as gender, age, ASA, BMI and Kellgren score did not correlate with 
trochanteric symptoms (Table 4).
Discussion
Trochanteric pain syndrome complicates up to 17% of cases after THA29,30 and has a 5- year post-operative inci-
dence of up to 4.9%, depending on the approach9. Although this complication can successfully treated with cor-
ticosteroid injections9,11, Silva et al. showed no evidence of bursitis or inflammation histologically after THA in 
patients with greater trochanteric pain syndrome31. Mahmood et al. showed, that a reduced global femoral offset 
less than 5 mm, leads to an aggravation in the functional outcome, especially of the abductor muscle strength15. 
This is in accordance with the findings of Spalding et al., who found a reduced motion and strength in the abduc-
tor muscle after reduced femoral offset reconstruction in THA16. Following these results, we presumed that a 
deviation of the three-dimensional hip biomechanics from the native situation might correlate with these symp-
toms after THA.
There are several limitations to our study. First, our results are based on 90 patients with unilateral osteoar-
thritis of the hip. Therefore, the study is restricted by numbers. However, a power calculation was performed 
preoperatively according to the posed hypothesis of the study. Second, patients with anatomical disorders such as 
dysplasia and patients with prior trauma were not included in the study because of the strict inclusion criteria of 
the main study. Such patients may have a different relation between individual anatomy and greater trochanteric 
pain syndrome. Third, a minimally-invasive, anterolateral approach to the hip was used in the current study. 
Previous studies assumed an association between trochanteric pain and the applied surgical approach. Disruption 
of soft tissue during a lateral approach with resultant abductor tear, tendon defects and tendinitis might be asso-
ciated with the postoperative prevalence of TPS whereas anterior and posterior approaches might be less prone to 
TPS. Therefore, the results might be different when using a different surgical approach9.
Fourth, there might be different reasons for the development of trochanteric pain syndrome like gait distur-
bances or lower back problems. We did not analyze these factors particularly, but we have to emphasize that no 
patient in out cohort had symptoms of a trochanteric pain syndrome before surgery. A strength of our study is its 
HHS 
preop












THR 3 y 
postop
No TPS
mean 50.2 97.0 38.5 90.1 0.6 1.0 84.9 87.1
SD 10.3 6.7 12.4 11.2 0.3 0.1 14.6 14.8
minimum 22 57.0 1.9 45.0 0.1 0.7 30.6 37.5
maximum 67.0 100 62.5 100.0 1.0 1.0 100.0 100.0
TPS
mean 47.9 93.1 38.1 81.4 0.6 0.9 80.9 74.8
SD 14.4 8.6 15.2 17.3 0.3 0.2 15.3 16.1
minimum 10.0 64.0 5.0 37.5 0.1 0.1 48.6 28.9
maximum 64.0 100 64.4 100.0 1.0 1.0 100.0 100
p-value 0.80 0.006 0.80 0.03 0.55 0.003 0.27 0.001
Table 3. Harris-Hip-Score (HHS), Hip Disability And Osteoarthritis Outcome Score (HOOS), EuroQol (EQ-
5D) and Hospital for Special Surgery Total Hip Replacement Expectations (THR) Survey were obtained before 
and three years after THA according to the development of trochanteric pain syndrome. For quantitative data 
values are given as mean (SD = standard deviation). TPS = trochanteric pain syndrome, preop = preopertavie, 
postop = postoperative, SD = Standard Deviation.
HR 95% CI P-value
Combined LL/FO/AO 1.1 1.0–1.3 <0.01
Gender 0.8 0.3–2.5 0.7
Age 1.0 0.9–1.0 0.4
ASA 1.5 0.6–3.8 0.3
BMI 1.0 0.9–1.1 0.9
Kellgren 0.7 0.4–1.4 0.3
Table 4. Multivariate analysis of risk factors associated with trochanteric pain syndrome. HR = Hazard Rate, 
CI = Confidence Interval, Combined LL/FO/AO = sum of absolute values of the differences of leg length (LL), 
femoral offset (FO) and acetabular offset (AO) between operated and nonoperated side. ASA = American 
Society of Anaesthesiologists, BMI = Body Mass Index.
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3D-CT scan dependent measuring protocol of leg length, femoral and acetabular offset, which allowed an exact 
determination of the anatomy of the hip joint and the used parameters, minimalizing inaccuracy as it occurs on 
plain radiographs due to projection failures17.
In answer to the first question of the study, we found patients with Greater trochanteric pain syndrome three 
years after THA had a higher absolute discrepancy of combined leg length, femoral and acetabular offset res-
toration compared to the non-operated contralateral side than patients without symptoms in the trochanteric 
region. Due to the fact, that we used absolute values, both over- as well as underrestoration of leg length and offset 
compared to the non-operated side are associated to greater trochanteric pain syndrome after THA. Patients with 
an absolute deviation of combined biomechanical restoration of leg length, femoral and acetabular offset of more 
than 5 mm complained approximately three times more frequently about trochanteric symptoms, than patients 
with a biomechanical restoration within 5 mm compared to the non-affected contralateral side. So there seems 
to be a tolerance interval for the reconstruction of femoral offset, acetabular offset, and leg length within these 
5 mm at least. This is in accordance with two previous studies, which showed, that a reduced global femoral offset 
less than 5 mm, lead to an aggravation in the functional outcome, especially of the abductor muscle strength and 
that a leg length and offset difference over 5 mm was associated with altered gait kinematics14,15. Interestingly, our 
results show that the discrepancy of one single biomechanical parameter such as leg length, femoral or acetabular 
offset was not different between patients with and without trochanteric symptoms. These results are in accordance 
with the findings of Abdulkarim et al., who showed no relationship between greater trochanteric pain syndrome 
and femoral offset or femoral center of rotation29. These results suggest, that the restoration of hip anatomics in 
THA has to be assessed three-dimensionally17.
Furthermore, this study showed that clinical outcome measured three years after THA such as HHS, HOOS 
and EQ-5D was significantly lower in patients with trochanteric symptoms than patients without trochanteric 
pain, as well as fulfillment of patient expectations as measured by THR-Survey was lower in the patient with 
Greater trochanteric pain syndrome. These results emphasize the clinical relevance of Greater trochanteric pain 
syndrome on outcome and satisfaction of patients after THA. To classify these results, it is necessary to take a look 
at the general outcome after THA. A recent study, which analyzed 1234 primary total hip replacements, showed 
excellent outcome for patients after THA with a positive responder rate of 93% and corresponding PROMs using 
WOMAC and EQ-5D32. This is in accordance with different studies, which analyzed the long-term outcome of 
patients after primary THA33–35. The promising results in outcome even apply to patients with severe diseases like 
haemophilia and rheumathoid arthritis36,37.
In addition, the results of Robertson-Watres et al. showed a poor outcome for patients with surgical treatment 
for greater trochanteric pain syndrome after THA, analyzing patient satisfaction score; 10 cm visual analogue 
score referring to current level of pain (0–100, 0 representing no pain); Oxford hip score; Likert scale duration of 
pain relief following the operation; Binary presence of pain when lying on affected side8. This confirms the impor-
tance of accurate three-dimensional restoration of the hip joint biomechanics and shows the necessity to prevent 
this complication already during the initial surgery.
conclusion
In conclusion, combined restoration of leg length, acetabular and femoral offset is crucial in THA. An exact 
combined restoration of these biomechanical parameters reduces significantly postoperative trochanteric pain 
syndrome and improves the clinical outcome of the patients. A restoration up to 5 mm seems to be safe for avoid-
ing this complication.
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